News

The pipeline described in the the PhD thesis by Anssi Lipponen, MSc, provides a rational stepwise procedure for evaluating the effects of systems-biology–discovered compounds to be repurposed for TBI and to accelerate discovery of drugs for TBI.

The detection of somatic mutations has yielded better disease classifications and the identification of patients with adverse outcomes.